Showing results (41-50 of 180) with videos related to
Sort By:
Pageof 18
Plos One|July 22, 2017
In Vitro comparison of 213Bi- and 177Lu-radiation for peptide receptor radionuclide therapyHo Sze Chan, Erik de Blois, Alfred Morgenstern, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 6, 2024
Deescalated 225Ac-PSMA-617 Versus 177Lu/225Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 PatientsHendrik Rathke, Erik Winter, Frank Bruchertseifer, et al.Molecular Cancer Therapeutics|July 23, 2013
Targeting aberrant DNA double-strand break repair in triple-negative breast cancer with alpha-particle emitter radiolabeled anti-EGFR antibodyHong Song, Mohammad Hedayati, Robert F Hobbs, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 13, 2012
Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosisMarkus Essler, Florian C Gärtner, Frauke Neff, et al.Immunotherapy|September 15, 2011
Analysis of patient survival in a Phase I trial of systemic targeted α-therapy for metastatic melanomaBarry J Allen, Apresh A Singla, Syed M Abbas Rizvi, et al.Molecular Cancer Therapeutics|November 21, 2015
Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial AnaloguesCharles Zhu, Amey Bandekar, Michelle Sempkowski, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 16, 2021
Dose escalation study of targeted alpha therapy with [225Ac]Ac-DOTA-substance P in recurrence glioblastoma - safety and efficacyLeszek Królicki, Frank Bruchertseifer, Jolanta Kunikowska, et al.Biomaterials|April 3, 2017
Alpha-particle radiotherapy: For large solid tumors diffusion trumps targetingCharles Zhu, Michelle Sempkowski, Timothy Holleran, et al.Clinical Nuclear Medicine|February 28, 2023
Locoregional Treatment of Glioblastoma With Targeted α Therapy: [ 213 Bi]Bi-DOTA-Substance P Versus [ 225 Ac]Ac-DOTA-Substance P-Analysis of Influence ParametersLeszek Królicki, Jolanta Kunikowska, Frank Bruchertseifer, et al.EJNMMI Physics|May 9, 2024
Quantitative SPECT/CT imaging of actinium-225 for targeted alpha therapy of glioblastomasMonika Tulik, Radosław Kuliński, Zbisław Tabor, et al.Pageof 18